Spanish medtech caught in Euro200 million contributions law
This article was originally published in Clinica
Executive Summary
Suppliers of medical products to Spain's national healthcare system (SNS) will soon be obliged to contribute a percentage of their sales to support R&D and regional services delivery, under new legislation. The move is expected to generate Euros200m ($258m) per annum, double the current level.